Lundbeck wins European approval for alcohol pill
The EU Commission has awarded marketing authorization to a pill from the Danish company Lundbeck for the treatment of alcohol addiction. The company estimates a top sales potential of several billions, while analysts are more cautious.
by Kresten Morten Munksgaard
Lundbeck’s new drug for alcohol addiction is ready to help European patients after the EU Commission Thursday told the company that its application for marketing of the drug had been approved.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
